Roll over image to zoom in
Dasanix (Sprycel) Dasatinib 50mg online
$276.00
Status: In stock
A kinase inhibitor indicated for newly diagnosed adults with Philadelphia chromosome-positive chronic myeloid leukaemia in chronic phase. It is also used for adults with chronic, accelerated, or blast phase Ph+ CML and for adults with Ph+ acute lymphoblastic leukaemia with resistance or intolerance to prior therapy, and for paediatric patients with Ph+ CML in chronic phase.
Dasanix (SPRYCEL) 50mg is a kinase inhibitor indicated for the treatment of
1. newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
2. adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.
3. adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
4. pediatric patients with Ph+ CML in chronic phase
DOSAGE AND ADMINISTRATION
1. Chronic phase CML in adults: 100 mg once daily.
2. Accelerated phase CML, myeloid or lymphoid blast phase CML, or Ph+ ALL in adults: 140 mg once daily.
3. Chronic phase CML in pediatrics: starting dose based on body weight.
4. Administer orally, with or without a meal. Do not crush, cut, or chew tablets.
Dasanixâs brand name is SPRYCELÂźby Bristol-Myers Squibb.Dasanix is a kinase inhibitor prescription medicine from Beacon, which is one of the biggest pharmaceutical company in Bangladesh.
For more Prescribing informationïŒplease check the â âFDA Prescribing Informationâ.
1. newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
2. adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.
3. adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
4. pediatric patients with Ph+ CML in chronic phase
DOSAGE AND ADMINISTRATION
1. Chronic phase CML in adults: 100 mg once daily.
2. Accelerated phase CML, myeloid or lymphoid blast phase CML, or Ph+ ALL in adults: 140 mg once daily.
3. Chronic phase CML in pediatrics: starting dose based on body weight.
4. Administer orally, with or without a meal. Do not crush, cut, or chew tablets.
Dasanixâs brand name is SPRYCELÂźby Bristol-Myers Squibb.Dasanix is a kinase inhibitor prescription medicine from Beacon, which is one of the biggest pharmaceutical company in Bangladesh.
For more Prescribing informationïŒplease check the â âFDA Prescribing Informationâ.
Related products
Recently Viewed Products
